Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Pfizer gets USFDA nod for Braftovi plus Mektovi for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer

Ruchika Sharma14 Oct 2023 10:30 AM IST

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib)...

India seeks corrective action from cough syrup firm Marion Biotech linked to Uzbek deaths

Ruchika Sharma13 Oct 2023 3:57 PM IST

"The firm will not carry out any medicine manufacturing work until the final decision of the appellate authority,"Gupta said.

CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study

Sun Pharma Cequa Phase 4 data shows sustained improvement in Dry Eye Disease signs, symptoms in patients switched from Restasis

Ruchika Sharma13 Oct 2023 2:29 PM IST

Mumbai: Sun Pharmaceutical Industries Limited has announced the presentation of Phase 4 data showing that CEQUA (cyclosporine ophthalmic solution)...

Lupin secures SBTi validation for emission reduction targets

Lupin gets tentative USFDA nod for generic equivalent of Xywav Oral Solution

Ruchika Sharma13 Oct 2023 12:38 PM IST

Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch.

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Panacea Biotec Pharma Baddi facility gets 9 USFDA observations

Ruchika Sharma13 Oct 2023 11:30 AM IST

Punjab: Panacea Biotec Limited has announced that the Company’s material wholly-owned subsidiary, Panacea Biotec Pharma Limited...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

USFDA issues 9 observations for Dr Reddy's Labs Hyderabad facility

Ruchika Sharma13 Oct 2023 10:30 AM IST

Hyderabad: Pharma major, Dr Reddy's Labs, has announced that the United States Food & Drug Administration (USFDA) has concluded a product...

Cipla arm New York facility gets EIR from USFDA

Ruchika Sharma12 Oct 2023 3:30 PM IST

Mumbai: Cipla has announced that the New York manufacturing facility of InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of the Company,...

Goa Invokes ESMA, Bans Pharma Strikes for 6 Months

No strike allowed in Goa pharma units, Govt extends ESMA by 6 months

Ruchika Sharma12 Oct 2023 2:36 PM IST

Panaji: With an aim of ensuring the uninterrupted production and supply of pharmaceuticals, the Goa government has decided to extend the Essential...

Aster India unit draws suitors valuing business at USD 1.5 billion: Bloomberg

Ruchika Sharma12 Oct 2023 1:30 PM IST

New Delhi: Private equity firm BPEA EQT and Ontario Teachers’ Pension Plan Board are among firms considering a deal to acquire Aster DM Healthcare...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb Sotyktu long term data demonstrate durable efficacy, consistent safety for up to 3 years in moderate-to-severe Plaque Psoriasis

Ruchika Sharma12 Oct 2023 12:50 PM IST

Princeton: Bristol Myers Squibb has announced new three-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu...

USFDA finds no misconduct at trial sites for Pfizer Lyme disease vaccine

Ruchika Sharma12 Oct 2023 11:33 AM IST

The Boston-based company denied allegations of breach of clinical trial guidelines, and said the USFDA's inspection did not result in any Form 483...

India allows cough syrup firm linked to Uzbek deaths to re-open factory

Ruchika Sharma11 Oct 2023 5:30 PM IST

New Delhi: India's northern state of Uttar Pradesh has permitted the resumption of most production at a factory owned by Marion Biotech, which...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok